Abnova FISH probes for cancer research
Abnova provides a collection of fluorescence in situ hybridisation (FISH) probes targeting various potential prognostic biomarkers for oncology. The company’s cytogenetic probes enable high hybridisation efficiency, ready for the rapid identification of chromosomal abnormalities — such as amplifications, translocation, fusion and splitting — that are frequently encountered across the genome.
Designed for the purpose of pinpointing DNA targets in cells and in tissues, the FISH probes will facilitate further research for lung adenocarcinoma, ovarian cancer, pancreatic cancer, prostate cancer and more.
Phone: 02 9698 2022
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
Immundiagnostik ID-Vit MTP assays
Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...
Bertin Bioreagent obesity research ELISA kits
Bertin Bioreagent's obesity research ELISA kits include targets for 20-hydroxyecdysone,...
